GSK3B and breast cancer: In our study, we found that GSK3β negatively regulates EZH2′s enzymatic activity, which is reflected by the expression of H3K27 trimethylation, without altering EZH2 protein level, and this observation was further supported by our immunohistochemical staining analysis in human breast cancer tissue samples.